𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity

✍ Scribed by Bufalo, Donatella Del; Trisciuoglio, Daniela; Scarsella, Marco; Zangemeister-Wittke, Uwe; Zupi, Gabriella

Book ID
110068085
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
213 KB
Volume
22
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Induction of apoptosis and chemosensitiz
Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment
✍ Sally Hopkins-Donaldson; Richard Cathomas; A. Paula SimΓ΅es-WΓΌst; Stefanie Kurtz; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 317 KB

## Abstract Our study was designed to investigate the role of the anti‐apoptotic proteins Bcl‐2 and Bcl‐xL in the chemoresistance of cells derived from malignant pleural mesothelioma. First, we determined the basal expression levels of Bcl‐2 and Bcl‐xL in mesothelioma cells and examined the effect

Inhibition of progression to androgen-in
Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense BCL-XL and antisense Bcl-2 oligonucleotides plus taxol after castration in the Shionogi tumor model
✍ Hideaki Miyake; Brett P. Monia; Martin E. Gleave πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 184 KB πŸ‘ 2 views

We have reported that antisense Bcl-2 oligodeoxynucleotide (ODN) delays progression to androgen independence in the androgen-dependent (AD) mouse Shionogi tumor model. Here, we characterize changes in bcl-xL, another important anti-apoptotic gene, and test the efficacy of adjuvant antisense Bcl-xL O